LFAnt develops embedded lateral flow sensors within its Compact platform, enabling accurate bioanalytical testing for early disease detection and diagnosis. This technology enhances accessibility to timely health assessments, particularly in underserved areas facing public health challenges.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional diagnostic testing often requires specialized equipment and trained personnel, limiting accessibility, particularly in underserved areas and point-of-care settings. This can lead to delays in diagnosis and treatment, especially for conditions requiring timely intervention.
Solution
LFAnt Medical's Compact platform is a digitally enabled, portable testing solution designed for rapid and accurate bioanalytical testing. The platform utilizes embedded lateral flow sensors to detect and diagnose a range of diseases and health-related conditions. By automating results interpretation and offering Bluetooth connectivity, the Compact aims to improve accessibility to timely health assessments, enabling testing outside of traditional clinical settings. The platform connects users to telemedicine providers, facilitating prompt access to care and support.
Target Audience
The primary target audience includes individuals in underserved areas, healthcare providers seeking point-of-care diagnostic solutions, and individuals who require convenient and accessible health monitoring.
Features
- Compact, handheld design for point-of-care and at-home testing
- Embedded lateral flow sensors for accurate bioanalytical detection
- Automated results interpretation, reducing the need for manual analysis
- Bluetooth connectivity for seamless data transfer to mobile devices
- Mobile app providing reliable health information and metrics
- Direct connection to telemedicine providers for convenient access to care